English
|
Spanish
Supporting oncology professionals through education
Login
Register
The content on this site is intended for healthcare professionals only
Menu
Home
News
Journal
Video
e
learning
Events
Conferences
About us
Keyword
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas
News
Latest news
Sign up for news alerts
Submit your news
Explore
Bone
Brain & nervous system
Breast
Colorectal & gastro
Haematology oncology
Head & neck
Hepatobiliary pancreatic
Lung & pleura
Melanoma & skin
Neuroendocrine
Ovary & gynaecology
Paediatric
Prostate & urology
Sarcomas
Journal information
Journal home
Charges
Editorial board
Founding editors
Editor-in-chief
Contact us
Author information
Submit article
Author guidelines
Editorial policies
Copyright information
Why publish with us
Reviewer information
Reviewer guidelines
Memberships
Videos
Recent videos
Sign up
Explore
Bone
Brain & nervous system
Breast
Colorectal & gastro
Haematology oncology
Head & neck
Hepatobiliary pancreatic
Lung & pleura
Melanoma & skin
Neuroendocrine
Ovary & gynaecology
Paediatric
Prostate & urology
Sarcomas
Conferences
Latest conferences
Sign up for latest coverage
Submit your event
About
e
cancer
About
e
cancer
Our founders
Funding statement
Contact us
Home
News
Journal
Video
e
learning
Events
Conferences
About us
Keyword
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
+
-
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas
e
cancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.
Please login or register. Then you can use this button to confirm you are part of this project.
Register for free
Already have an account?
Login
Videos
[2217]
News
[4956]
Articles
[119]
Editorials
[4]
Conferences
[153]
e
learning
[8]
ASCO GI 2022: Durvalumab plus tremelimumab significantly improves survival for patients with advanced liver cancer...
ASCO GI 2022: Durvalumab significantly improves survival for patients with biliary tract cancer compared to...
ASCO GI 2022: Pembrolizumab significantly improved OS versus placebo in certain patients with advanced HCC...
Combination therapies may improve outcomes due to independent, rather than synergistic or additive, drug action
Magnesium is essential for the immune system, including in the fight against cancer
New treatment target ID’d for radiation-resistant cervical cancer
First-in-human trial with CAR macrophages shows the cell therapy may be safe, feasible for solid tumours
Identification of a novel therapeutic target in multiple myeloma
Journeys - a photo essay
Researchers identifies new drug combo for liver cancer via CRISPR-Cas9 screen
<
1
...
116
117
118
119
120
...
496
>
More from
e
cancer